Ikonisys S.A.

ENXTPA:ALIKO Stock Report

Market Cap: €16.7m

Ikonisys Valuation

Is ALIKO undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

2/6

Valuation Score 2/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Sales vs Peers

  • Price-To-Sales vs Industry

  • Price-To-Sales vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of ALIKO when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: ALIKO (€1.4) is trading below our estimate of fair value (€18.55)

Significantly Below Fair Value: ALIKO is trading below fair value by more than 20%.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for ALIKO?

Key metric: As ALIKO is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.

The above table shows the Price to Sales ratio for ALIKO. This is calculated by dividing ALIKO's market cap by their current revenue.
What is ALIKO's PS Ratio?
PS Ratio33.4x
Sales€471.50k
Market Cap€16.67m

Price to Sales Ratio vs Peers

How does ALIKO's PS Ratio compare to its peers?

The above table shows the PS ratio for ALIKO vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PSEstimated GrowthMarket Cap
Peer Average4x
ALTHE Theraclion
12.2xn/a€15.7m
ALTER Theradiag
1.2xn/a€16.4m
ALDMS Diagnostic Medical Systems
0.3xn/a€13.6m
ALIMP Implanet
2.2xn/a€15.9m
ALIKO Ikonisys
33.4x51.0%€16.7m

Price-To-Sales vs Peers: ALIKO is expensive based on its Price-To-Sales Ratio (33.4x) compared to the peer average (4x).

Price to Sales Ratio vs Industry

How does ALIKO's PS Ratio compare vs other companies in the FR Medical Equipment Industry?

7 CompaniesPrice / SalesEstimated GrowthMarket Cap
GBT Guerbet
0.4x6.1%US$352.17m
ALBIO Biosynex
0.3xn/aUS$31.98m
ALDMS Diagnostic Medical Systems
0.3xn/aUS$14.31m
ALEMG Laboratoires Euromedis Société anonyme
0.4x8.3%US$13.72m
ALIKO 33.4xIndustry Avg. 3.5xNo. of Companies7PS02.44.87.29.612+
7 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Sales vs Industry: ALIKO is expensive based on its Price-To-Sales Ratio (33.4x) compared to the European Medical Equipment industry average (3.5x).

Price to Sales Ratio vs Fair Ratio

What is ALIKO's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

ALIKO PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio33.4x
Fair PS Ratio2.8x

Price-To-Sales vs Fair Ratio: ALIKO is expensive based on its Price-To-Sales Ratio (33.4x) compared to the estimated Fair Price-To-Sales Ratio (2.8x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst ALIKO forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
Current€1.40
€4.10
+192.9%
34.1%€5.50€2.70n/a2
Nov ’25€1.48
€4.10
+177.0%
34.1%€5.50€2.70n/a2
Oct ’25€1.57
€4.10
+161.1%
34.1%€5.50€2.70n/a2
Nov ’24€1.25
€7.25
+480.0%
37.9%€10.00€4.50€1.482
Oct ’24€1.23
€7.25
+489.4%
37.9%€10.00€4.50€1.572
Sep ’24€1.49
€7.25
+386.6%
37.9%€10.00€4.50€1.482
Aug ’24€1.60
€7.25
+353.1%
37.9%€10.00€4.50€1.492
Jul ’24€1.65
€7.25
+339.4%
37.9%€10.00€4.50€1.422
Jun ’24€1.65
€7.25
+339.4%
37.9%€10.00€4.50€1.462
May ’24€1.71
€8.35
+388.3%
19.8%€10.00€6.70€1.402
Apr ’24€1.73
€8.35
+384.1%
19.8%€10.00€6.70€1.482
Mar ’24€1.85
€8.35
+352.6%
19.8%€10.00€6.70€1.522
Feb ’24€1.80
€8.35
+363.9%
19.8%€10.00€6.70€1.442
Jan ’24€1.45
€8.35
+475.9%
19.8%€10.00€6.70€1.562
Dec ’23€1.52
€8.35
+451.2%
19.8%€10.00€6.70€1.542
Nov ’23€1.74
€8.35
+379.9%
19.8%€10.00€6.70€1.252

Analyst Forecast: Target price is more than 20% higher than the current share price, but there are not enough analysts covering the stock to determine statistical confidence in agreement.

Discover undervalued companies

Equasens Société anonyme

€625.3m

Provides healthcare IT solutions in Europe.

EQS

€41.60

7D

-5.5%

1Y

-26.8%

Laboratoires Euromedis Société anonyme

€13.0m

Through its subsidiaries, designs, manufactures, and distributes medical equipment under the Euromedis brand name for healthcare professionals, local communities, and individuals in France and internationally.

ALEMG

€4.57

7D

-4.2%

1Y

-3.8%

emeis Société anonyme

€901.5m

Operates nursing homes, assisted-living facilities, post-acute and rehabilitation hospitals, and psychiatric hospitals.

EMEIS

€5.60

7D

-10.5%

1Y

-98.3%